Company
Therini Bio
Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
Also known as Therini Bio, Inc, TheriniBio
- Business model
- B2B
- Legal name
- Therini Bio, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Therini Bio is a vascular biology company focused on developing novel therapies based on a deep understanding of fibrin and its role in driving pathological inflammatory processes.
Funding snapshot
- Total raised
- $84.2MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $74.9M2023-03-29
Funding rounds
- Round, 2023
- $74.9M2023-03-29, SEC form D sold, 17 investors
- Round, 2019
- $9.4M2019-05-08, SEC form D sold, 4 investors
Products
- Web
- THN391
Loading relationship preview